Shen-fu Injection Modulates HIF- 1α/BNIP3-Mediated Mitophagy to Alleviate Myocardial Ischemia–Reperfusion Injury

Apr 17, 2025Cardiovascular toxicology

Shen-fu Injection May Reduce Heart Damage by Adjusting Cell Recycling Controlled by Low Oxygen Pathways

AI simplified

Abstract

Shen-fu Injection (SFI) significantly reduces the area of myocardial infarction and improves cardiac function in a rat model of ischemia-reperfusion injury.

  • HIF-1α and BNIP3 are identified as key targets in myocardial ischemia-reperfusion injury (MIRI).
  • SFI upregulates HIF-1α expression, which promotes moderate mitophagy to clear damaged mitochondria.
  • This clearance process is associated with a reduction in cardiomyocyte apoptosis and myocardial injury.
  • SFI also lowers reactive oxygen species (ROS) production and stabilizes mitochondrial membrane potential.
  • The use of SFI leads to a decrease in autophagosome accumulation, suggesting improved cellular health.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free